Availability of Resolor® (prucalopride)

Movetis did obtain in October 2009 the marketing authorisation for Resolor® and is authorised to market the product in the European Economic Area (EEA).

Because of pricing and reimbursement formalities, the product will be launched in the EEA countries at different timepoints.

Since January 15, 2010, Resolor® is commercially available in Germany.

A collaboration with the UK-based company IDIS was set up in order to provide pre-launch access to Resolor® in those countries where such pre-launch access is allowed under the local regulations. Physicians and pharmacists can contact IDIS for more information (www.idispharma.com).

Please check this page for the latest updates.